Nesacaine Injection, Solution
Product Images NDC 63323-477

10 FDA label images from Fresenius Kabi Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Nesacaine (NDC 63323-477). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Nes01 0002 01)

Structure (Nes01 0002 01)
Chemical structure of Chloroprocaine Hydrochloride, showing the molecular arrangement including an amine group, chlorine atom, ester linkage, and hydrochloride component.*
FDA Label Image

Fresenius Kabi Logo (Nes01 0002 02)

FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
Label for Nesacaine 1% (chloroprocaine HCl Injection, USP), 10 mg/mL strength, 30 mL multiple dose vial by Fresenius Kabi USA, LLC. Intended for infiltration and nerve block only, not for caudal, epidural, or spinal anesthesia. The label includes storage instructions, sterility, and preservative information.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
Nesacaine 1% (chloroprocaine HCl Injection) 10 mg/mL solution for infiltration and nerve block, in a 30 mL multiple dose vial. Label indicates formulation contains methylparaben and preservatives, and is manufactured by Fresenius Kabi USA, LLC.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
Nesacaine 2% (chloroprocaine HCl Injection, USP) solution, 20 mg/mL concentration in a 30 mL multiple dose vial. Label specifies use for infiltration and nerve block only, not for caudal, epidural, or spinal anesthesia. Contains methylparaben as a preservative. Manufactured by Fresenius Kabi USA, LLC, with storage instructions to protect from light, store at 20° to 25°C, and keep from freezing.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
Nesacaine 2% (chloroprocaine HCl injection, USP) label for 20 mg/mL strength in 30 mL multiple dose vials. It is sterile, nonpyrogenic, with chloroprocaine HCl and other components listed. The label states it is for infiltration and nerve block only, not for caudal, epidural, or spinal anesthesia, and includes storage instructions. The labeler is Fresenius Kabi USA, LLC.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
Label for Nesacaine-MPF (chloroprocaine HCl Injection, USP) 2% solution, containing 400 mg per 20 mL (20 mg per mL) in a 20 mL single-dose vial. Indicated for infiltration, nerve block, caudal, and epidural anesthesia, not for spinal anesthesia. The label states it is methylparaben free and EDTA free. Manufactured by Fresenius Kabi USA, LLC, with storage instructions and warnings visible.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
Nesacaine-MPF 20 mg/mL (2%) Chloroprocaine HCl Injection, USP label for 25 single dose vials of 20 mL each. The label notes it is methylparaben and EDTA free, for infiltration, nerve block, caudal and epidural anesthesia but not for spinal anesthesia. Manufactured by Fresenius Kabi USA, LLC.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
Packaging label for Nesacaine-MPF injection, 3% chloroprocaine hydrochloride solution, 30 mg/mL (600 mg per 20 mL) in a 20 mL single-dose vial. The label indicates use for infiltration, nerve block, caudal, and epidural anesthesia, excluding spinal anesthesia. It is methylparaben and EDTA free. The product is sterile, nonpyrogenic, and labeled by Fresenius Kabi USA, LLC.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
Nesacaine-MPF 3% (chloroprocaine HCl Injection, USP) is an injection solution containing 30 mg/mL of chloroprocaine HCl. The label indicates 25 single-dose vials of 20 mL each. It is for infiltration, nerve block, caudal, and epidural anesthesia but not for spinal anesthesia. The product is methylparaben-free, EDTA-free, and intended for prescription use only. Manufactured by Fresenius Kabi USA, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.